Rofecoxib-associated upper gastrointestinal bleed: A case report

Mount Sinai Journal of Medicine

Volumn 69, Issue 1-2, 2002, Pages 105-106

  Freedman, Gordon M ^a   Kreitzer, Joel M ^a   Badola, Ruchi ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclo oxygenase 2 inhibitor; Nonsteroidal anti inflammatory drug; Peptic ulceration; Rofecoxib; Upper gastrointestinal bleed

Indexed keywords

ACETYLSALICYLIC ACID; CLONAZEPAM; OMEPRAZOLE; OXYCODONE; PREDNISONE; ROFECOXIB;

ADULT; ANALGESIA; ARTICLE; CASE REPORT; CONSERVATIVE TREATMENT; CROHN DISEASE; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG WITHDRAWAL; HUMAN; MALE; PATIENT CARE; PEPTIC ULCER; PRESCRIPTION; RHEUMATOID ARTHRITIS; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CROHN DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LACTONES; MALE; MIDDLE AGED; PEPTIC ULCER; SULFONES;

EID: 0036149579     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models
2. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use
3. Aspirin selectively inhibits prostaglandin production in human platelets
4. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system
5. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs
6. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
7. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis
8. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis
9. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
10. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects
11. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs